RANZCP response to new National Health and Medical Research Council guidelines on the care of trans and gender diverse people
16 Nov 2026
Media release
The RANZCP acknowledges the NHMRC’s interim advice on the use of puberty suppressants for trans and gender-diverse young people and recognises its efforts to strengthen the evidence base and inform the development of rigorous, evidence-informed clinical guidance.
The College supports a comprehensive, individualised approach to care that prioritises the health, wellbeing and best interests of young people, respects their autonomy and ensures access to appropriate psychological, psychosocial and medical treatment and support options.
The RANZCP is reviewing the NHMRC’s interim advice through its expert committees and will contribute to the public consultation, including consideration of the evidence, recommendations and implications for the mental health care of trans and gender-diverse young people.
Quotes attributable to RANZCP President Dr Astha Tomar:
“Trans and gender-diverse young people deserve access to respectful, compassionate, evidence-informed and non-judgmental healthcare that responds to their individual needs and circumstances.
“Care must not be reduced to any single medical intervention. It should encompass a range of treatment and support options, recognising that no single approach is appropriate for every young person.
“Clinical decisions should be guided by comprehensive multidisciplinary assessment, the best available evidence and supported decision-making that respects the young person’s autonomy and evolving capacity, with involvement of families or carers where appropriate.
“This includes careful consideration of the potential benefits, risks and uncertainties of different options, as well as the consequences of both providing and withholding treatment.
“While the evidence continues to evolve, we must acknowledge its limitations and support further high-quality research and long-term monitoring of outcomes. However, uncertainty should not automatically lead to blanket restrictions that prevent access to appropriate care.
“Above all, our focus must remain on ensuring that young people receive timely, safe and individualised care, with decisions guided by their clinical needs, circumstances and informed preferences.”
ENQUIRIES: For more information, or to arrange an interview, call on +61 437 315 911 or email media@ranzcp.org.
The Royal Australian and New Zealand College of Psychiatrists is a membership organisation that prepares medical specialists in the field of psychiatry, supports and enhances clinical practice, advocates for people affected by mental illness and advises governments and other groups on mental health care. For information about our work, our members or our history, visit www.ranzcp.org.
In Australia: If you or someone you know needs help, contact Lifeline on 13 11 14 or www.lifeline.org.au or the Suicide Callback Service on 1300 659 467 or www.suicidecallbackservice.org.au.
In New Zealand: If you or someone you know needs help, contact Lifeline NZ on 0800 543 354 or www.lifeline.org.nz or the Suicide Crisis Helpline on 0508 828 865 or www.lifeline.org.nz/suicide-prevention.
More news & views
Media release
People with serious and complex mental health conditions languishing in NSW prisonsNew South Wales (NSW) psychiatrists are calling for key reforms to the state’s corrections system to...
Media release
Patients need affordable psychiatric care and a system that can provide itThe Royal Australian and New Zealand College of Psychiatrists (RANZCP) recognises that high out-of-p...
Media release
RANZCP statement on mental illness, violence and public discourseThe Royal Australian and New Zealand College of Psychiatrists (RANZCP) extends its thoughts and supp...